Treatment or pharmaceutical composition for the prevention of allergic diseases including killed Lactobacillus acidophilus Elbis

摘要

The present invention relates to a pharmaceutical composition for the treatment or prevention of allergic diseases comprising a dead bacterium of Lactobacillus acidophilus LB strain as an active ingredient, by reducing the total IgE content in the blood, It can be used for the treatment and prevention of allergic diseases mediated by IgE and non-IgE mediated allergic diseases such as atopic dermatitis, allergic rhinitis, allergic conjunctivitis, hives, hay fever.